AI summary by TwinMind
Dr. Kat Arney | Rebel Cell: Cancer, Evolution and the Science of Life | Talks at Google
Talks at Google
59m 7s
Book Introduction and Background
- Cat Arney presents "Rebel Cell: Cancer Evolution and the Science of Life"
- Available now in UK, US release end of October 2020
- Print run delayed due to COVID-19
- Book explores cancer as evolutionary disease and ecology of the body
- Emerging idea gathering momentum over recent decades
- Potentially transformative way to think about ancient disease
Cancer Progress and Current State
- Significant progress made: 50% of UK cancer patients survive 10+ years (doubled within author's lifetime)
- Glass half full but need new thinking for advanced cancers to fill completely
- Current targeted therapy approach has limitations
- Need broader horizons beyond narrow range of targets
Cancer Across Life - Debunking Modern Disease Myth
- Cancer not modern human disease - widespread across multicellular life
- Found in: reptiles, amphibians, birds, bats, dinosaurs
- 77 million year dinosaur fossil with osteosarcoma discovered week of book launch
- Oldest fossil: 240 million year old proto-turtle with tumor
- 2014 study: hydra (tiny 3-cell-type organism) developed natural tumor
- Notable exceptions: comb jellyfish and sponges appear cancer-resistant
- Carlo Maley (Arizona State) testing sponges with radiation
- 250+ documented examples in ancient human populations globally
- Evidence across all multicellular life wherever researchers look
Cancer as Price of Multicellularity
- Cancer emerges as inevitable consequence of multicellular life
- 4 billion years ago: transition from unicellular to multicellular organisms
- Multicellular societies gain advantages: size, speed, niche exploitation
- But create potential for cellular "cheats" within tissue society
- Athena Aktipis (Arizona State): tissues as cellular societies, cancer cells as cheats
- Cheats take more resources, reproduce excessively, abandon cellular jobs
- Cancer as emergent property of multicellular tissue
- Reassuring message: not always patient's fault, inherent to multicellular life
- Speculation: multicellular aliens would likely have cancer
Genetic Bingo Theory vs Reality
- Traditional view: "genetic bingo theory" or somatic mutation theory
- Cancer starts when cell accumulates enough genetic mutations in right genes
- Fits with cellular society concept - mutations enable cheating
- Problem: assumes all other cells are normal
Normal Tissue Mutation Discovery
- Sanger Institute team (Phil Jones, Iñigo Martincorena, Peter Campbell) studied normal tissue
- First study: eyelid skin from cosmetic procedures
- Deep genome sequencing revealed normal skin as "patchwork of mutation"
- Many mutations would be called "cancer driver mutations" if found in tumors
- Esophageal tissue study: extensive mutations increase with age
- 20s vs 50s vs 70s showing progressive mutational accumulation
- Further studies: blood, endometrium (60s women mostly mutated cells)
- Conclusion: need to rethink simplistic "pocket of mutated cells" model
Cancer Rarity Paradox
- Population level: 1 in 2 people will be diagnosed with cancer
- Personal cellular level: incredibly rare given trillions of cells, billions of divisions
- Most people get only 1-2 individual cancers in lifetime
- Bodies remarkably successful at suppressing damaged cells
- Something uniquely suppressive in younger bodies
- Cancer risk increases significantly only after 60s
- Most time spent studying why we get sick, not why we stay well
Chromosomal Catastrophe - Sad Cells to Bad Cells
- Key question: what turns mutated "sad cells" into cancer "bad cells"
- Normal human chromosomes: 23 pairs, organized
- Aggressive breast cancer chromosomes: complete chaos
- Not just single gene mutations - chromosomal catastrophe required
- Aneuploidy: chromosomes doubled, lost, rearranged
- Chromothripsis: chromosomes shattered and stitched back together
- Chromosomal chaos provides "rocket fuel for evolution"
- Cancer as "bin fire/dumpster fire of evolution"
Targeted Therapy Limitations
- Current approach: find mutations, develop drugs targeting specific molecules
- Gleevec success story: chronic myeloid leukemia, targets specific faulty molecule
- Arguably most successful targeted cancer drug ever
- Misled field into thinking all cancers could be treated this way
- Approach followed for decades with marginal gains
Drug Resistance Problem
- Vemurafinib melanoma case study: dramatic initial response (15 weeks)
- Cancer returned aggressively within 8 weeks
- Cancers are patchwork of mutations like normal tissues
- Resistant cells always present in advanced cancers
- Targeted therapies select for resistant populations
- "Whack-a-mole" approach: try one drug, when fails try another
- Eventually run out of options
- Expensive drugs with minimal survival benefits (sometimes 9 days)
- Not the miracle cures headlines suggest
Evolutionary Treatment Strategies
- Bob Gatenby (Moffitt Cancer Center): mathematical approaches to cancer
- Uses population mathematics, game theory concepts
- Adaptive therapy inspired by pest management in agriculture
- Farmers accept some pest level, balance resistant vs sensitive populations
- Pesticide resistance incurs fitness penalty
- Don't eliminate all sensitive pests or resistant ones dominate
Adaptive Therapy Protocol
- Assumes mixture of drug-sensitive and drug-resistant cells
- Drug-sensitive cells grow faster (fitter) than resistant cells
- Need method to measure tumor burden
- Treat until cancer shrinks to target level (e.g., 50%)
- Stop treatment, allow sensitive cells to regrow and suppress resistant cells
- Resume treatment when cancer returns to original size
- Repeat cycles indefinitely
Adaptive Therapy Results
- Prostate cancer trial results: survival without progression increased from 18 months to 4 years
- Uses existing approved drug in different dosing strategy
- Not a cure but dramatically extends control period
- Counterintuitive: allowing cancer to regrow periodically
- Psychological challenge for patients to stop working treatment
Extinction Strategies
- Move beyond control to extinction thinking
- Childhood leukemia success: 1940s <5% survival to >90% today
- Achieved through strategic combination therapies causing population collapse
- Heath hen extinction example: hunting, habitat loss, low genetic diversity, environmental stresses
- Multiple simultaneous pressures drive species to extinction
- Need rational extinction combinations for adult cancers
- Some researchers testing pre-surgery combination approaches
Future Directions and Challenges
- Peter Campbell: goal to live long enough to die of something else first
- Cancer as evolving system within body ecology
- Cannot stop cancer with "magic bullet" any more than stopping hurricane with shotgun
- Need mathematical modeling for treatment combinations
- Regulatory challenges for multi-drug rational strategies
- Phase 0 in silico trials before human testing
- Shift from animal models to computational approaches
Societal Perspective Changes
- Nixon's "War on Cancer" failed - cannot declare war on biological concept
- Cannot eliminate cancer from multicellular beings
- "Cure" narrative problematic - cancer not one disease
- Each cancer unique evolutionary event in individual body
- Need shift from cure expectation to smarter, more effective treatments
- Psychological challenge of long-term control vs cure mentality
Personal Risk Factors
- Avoid deliberately increasing mutational burden (smoking, toxins, UV)
- Exercise protective but mechanism unclear
- Obesity increases inflammation, tissue damage
- Inflammation key driver enabling rogue cell emergence
- Balance between risk reduction and living life fully
- Inherent cancer risk cannot be eliminated completely
Diet and Alternative Approaches
- Ketogenic diets: limited evidence, individual variation
- Caution about "starving" cancer - may increase migration
- pH manipulation ineffective due to kidney regulation
- Local tumor environment manipulation more promising
- Need personalized approaches based on individual cancer characteristics
